Pondimin

Pondimin®

 Fenfluramin, see there.
References in periodicals archive ?
In Knowles v Wyeth-Ayerst, (85) a product liability action concerning the diet drug Pondimin, the court ordered a comparative evaluation of the content of the Canadian settlement whose approval was demanded and an earlier American settlement.
for various types of injuries associated with the weight loss drugs fen-phen, Pondimin and Redux.
Mealey said the new title is designed to provide comprehensive coverage of all litigation surrounding drugs and weight-loss products, including prscription drugs such as Pondimin, Redux, pentermine, Meridia, Xenical, and its over-the-counter version Alli, as well as the appetite suppressant phenylpropanolamine (PPA) and the similar weight-loss herb ephedra.
Mealey's said the new title is designed to provide comprehensive coverage of all litigation surrounding drugs and weight-loss products, including prscription drugs such as Pondimin, Redux, pentermine, Meridia, Xenical, and its over-the-counter version Alli, as well as the appetite suppressant phenylpropanolamine (PPA) and the similar weight-loss herb ephedra.
Approximately 18,000 lawsuits and over one hundred putative class actions were filed against Wyeth, (39) the manufacturer of two of the diet drugs involved: fenfluramine, which had been marketed under the brand name Pondimin, and dexfenfluramine, which had been marketed under the brand name Redux.
Pondimin (Ontario): Diet drug; fund of $11,240,789 (exclusive of legal fees); of that, $1.
based Wyeth also reported significant progress in resolving many of the tens of thousands of remaining lawsuits over Pondimin and Redux, the diet drugs it pulled from the market in September 1997 amid evidence they damaged heart valves.
New to the second edition are chapters on drugs for asthma, allergies, and anaphylaxis; drug induced nephrotoxicity; Pondimin and Redux litigation; and the inadequacy of the US system for drug warning.
Wyeth had withdrawn its Pondimin and Redux from the market after they were linked to heart problems.
Wyeth marketed the dangerous "fen" half of it--the drugs fenfluramine and dexfenfluramine, sold under the brand names Pondimin and Redux.
Wyeth produced two versions of fenfluramine: Pondimin and a newer chemical cousin, Redux, or dexfenfluramine.